glp-1 weight-loss drugs Medications for Weight Loss: How to Get Started | News The GLP-1 revolution: What UAB
Description
8 October 2024
Biochemistry 40 , 1318813200 (2001)
Some of his patients who lost coverage have started to regain weight, he said
The impact of the glucagon-like peptide 1 receptor agonist liraglutide on the streptozotocin-induced diabetic mouse kidney proteome
Common side effects include: Gastrointestinal Issues - This is the most common side effect, including constipation, cramps, diarrhea, nausea, vomiting, heartburn, and belching Fatigue Dizziness Allergic reactions, such as itching or rashes Injection site reactions (redness, swelling) Rare and more serious side effects can include: Pancreatitis Gallbladder issues Thyroid tumours Kidney problems Severe allergic reactions such as difficulty breathing and swelling of the face, lips, or throat Diabetic retinopathy Severe changes in mood or behaviour Please note that the more serious side effects are very rare
The mechanisms responsible for these effects are not entirely clear, but the slowing of gastric emptying may be the key driver
